Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...
Medscape

Dexcom Issues Recall for G7, ONE+ Apps for Software Issues

Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of ...
Drug Delivery Business

FDA identifies serious recall for Dexcom CGM mobile apps

The FDA identified a recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors as the most serious type.

DexCom extends drop to reach five-month low

DexCom (DXCM) stock declines after a short report, yet analysts from TD Cowen and Baird stay bullish on the company's ...
MobiHealthNews

Dexcom launches new titration module for basal insulin initiation

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...
MedCity News

Dexcom’s first-gen CGM sensor developed with Verily won’t see light of day, at least in the U.S.

Many have been following San Diego-based Dexcom’s partnership with Alphabet’s Verily, and in November the continuous glucose monitoring maker announced that it has changed the financial terms of the ...
FierceBiotech

Abbott, Dexcom agree to 10-year truce over diabetes sensor patent litigation

Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors for people with diabetes—just weeks after a ...
FierceBiotech

Dexcom goes hands-free, connecting its G7 diabetes sensor directly to the Apple Watch

Dexcom announced that its G7 diabetes sensor can now link directly to a user’s Apple Watch, allowing them to track their glucose readings in real-time even if their iPhone isn’t nearby. According to ...